In Vivo and Ex Vivo Microscopy: Moving Toward the Integration of Optical Imaging Technologies Into Pathology Practice.
OPTICAL IMAGING MODALITIES
Numerous optical imaging technologies exist that have the potential for clinical impact. In this paper, we focus on 2 imaging technologies (Table 1) that are commercially available for clinical applications: optical coherence tomography (OCT) and confocal microscopy.
Optical coherence tomography is a high-resolution optical imaging modality that generates depth-resolved, cross-sectional images with resolutions up to 10 pm. (2-5) Analogous to ultrasound, OCT uses near-infrared light, instead of sound, as its source. With OCT, contrast is generated endogenously based on optical index of refraction mismatches, with depth penetration of 2 to 3 mm within tissue. No exogenous contrast agents or transducing media are required. Technologic advancements occurring during the last decade have allowed for rapid image acquisition rates of more than 200 frames per second, such that large 3-dimensional scans at near-cellular resolution can be acquired in seconds. (6-13) OCT is well suited for superficial applications, such as retinal imaging. (14-17) The development of OCT catheters, which can perform either helical or longitudinal scanning, has led to many endoscopic applications. These include cardiovascular, upper and lower gastrointestinal, pulmonary, laryngeal, and genitourinary imaging. (9,18-60) Needle-based and laparoscopic OCT catheter devices have also been developed for imaging in solid organs, such as breast, pancreas, lung parenchyma, kidney, ovary, and prostate. (40,41,59,61-75) Swallowable, capsule-based OCT probes have also been developed for upper GI imaging without the need for sedation or traditional white light endoscopy. (76-80) Higher-resolution forms of OCT are also under development and have achieved resolutions of 1 [micro]m in the ex vivo setting. (81-840
Confocal microscopy is an optical imaging technique that typically uses a pinpoint beam of light scanned across a tissue to create an en face, or transverse, image. The pinpoint blocks out-of-focus light to generate very high-resolution images (<1 [micro]m). This method of obtaining subcellular resolution comes at a trade-off for depth penetration, with a maximum of 300 [micro]m. (85-88) Line-scanned confocal methods have also been developed. Confocal microscopy measures fluorescence emitted from tissue to generate contrast, which can either be from endogenous autofluorescence, from structures such as collagen, or from the use of exogenous fluorescent dyes, such as fluorescein, injected intravascularly or applied topically. (89) Confocal microscopy can be used for surface applications, such as dermatologic imaging. (90-93) Endoscope-based confocal imaging devices have been developed, termed confocal laser endomicroscopy (CLE), which allow for luminal organ imaging. Endoscope-based CLE is a device that incorporates a scanner into the endoscope to scan the pinpoint beam across the tissue to generate a 2-dimensional image. Probe-based CLE is a different device design that contains a fiber bundle to simultaneously acquire multiple pinpoint locations within tissue, allowing for 2-dimensional imaging. The field of view for these devices ranges from 200 to 600 pm, with imaging depths of 100 to 250 [micro]m. Image acquisition speeds also range from 1 to 12 frames per second, with the more rapid image acquisition allowing for video-rate imaging. Example applications of CLE include upper and lower gastrointestinal imaging, cystoscopy, and pulmonary imaging. (94-115) Needle-based confocal devices have also been developed, providing access to solid organ imaging. (116-120)
WHAT ARE IN VIVO AND EX VIVO MICROSCOPY?
In vivo microscopy defines imaging techniques, such as OCT and CLE, that allow tissue to be viewed in living patients, at high resolution, in real time, without tissue removal, fixation, freezing, or staining. Some of the most potent IVM applications have been developed in areas where conventional imaging techniques (such as white light endoscopy, computed tomography, magnetic resonance imaging, and mammography) have resolution limitations. In vivo microscopy technologies, such as OCT, enable rapid, high-resolution surveillance of large areas of tissue, such as the entire length of an esophagus, within minutes. This enables more precisely directed biopsies of image-specific anomalies, such as dysplasia in Barrett esophagus. It can also serve as a surrogate for frozen section, such as in Mohs surgery or breast resection. In vivo microscopy can also provide a method of microscopic assessment in sites that may preclude invasive biopsy procedures, such as in the eye, brain, and coronary arteries. It can also be used in scenarios where patients may be too frail to undergo an invasive biopsy, such as in fibrotic interstitial lung diseases. In vivo microscopy technologies can also provide intraprocedural biopsy guidance, such as the use of needle-based IVM for biopsy guidance in pulmonary nodules, breast lesions, and other organ systems. Optical imaging in the in vivo setting also provides unique opportunities for dynamic tissue assessment that are not attainable with traditional microscopy or EVM, such as the ability to visualize red blood cells moving within capillaries. Example applications for IVM are detailed in Table 2.
Ex vivo microscopy (EVM) offers the same capacity for high-resolution visualization of tissue without fixation, processing, and staining, but in tissue that has been removed from the patient. Ex vivo microscopy has the potential for many clinical applications that may enhance our practice as pathologists. Examples of applications include: (1) rapid assessment of biopsy adequacy without alteration or loss of biopsy tissue, which would be applicable to biopsies in many organ systems, (2) more directed sampling of specimens on the gross bench, (3) better specimen triaging and selection of tissue for genomic molecular studies and biobanking, and (4) intraoperative assessment of resections and sentinel lymph nodes as a complement to, or possibly in lieu of, frozen sections. Example applications of EVM are detailed in Table 3.
IVM AND EVM IMAGE INTERPRETATION: PARALLELS TO TRADITIONAL MICROSCOPY
In vivo microscopy and EVM provide microscopic images of tissue architecture, and thus the imaging features seen closely parallel the morphologic features pathologists assess and interpret during their routine clinical practice. For the vast majority of clinical applications, the characteristic imaging features of specific entities have been developed and validated using corresponding histologic features as the comparator. (24,25,29,54,55,58,59) In the same way that pathologists have learned to interpret immunohistochemical staining for routine diagnostic histopathology, air-dried Diff-Quik versus alcohol-fixed Papanicolaou staining in cytopathology preparations, and electron microscopy images for renal and muscle biopsies, IVM and EVM images are different but interpretable by pathologists who are already experts in microscopic diagnosis. OCT provides cross-sectional images that are very similar in orientation to traditional histology. The near-cellular resolution of OCT is analogous to low- to medium-power objectives using a standard microscope, providing predominantly microarchitectural information. Because of the rapid image acquisition speeds, large volumetric imaging stacks can be obtained with OCT that can be reconstructed in different planes, which has the advantage of being viewed in multiple planes simultaneously, similar in principle to computed tomography scans. Confocal microscopy provides transverse, or en face, views of tissue that are perpendicular to the tissue plane typically visualized with traditional microscopy. However, its high resolution allows for visualization of cellular detail analogous to high-power microscopy. Image processing software advances are also now able to convert grey value images to pseudocolor palettes, similar to routine histologic stains. Additionally, IVM and EVM provide new views of tissue and disease. These include 3-dimensional microarchitecture, views across multiple tissue planes, features not overtly visible by standard microscopy, and new modes of tissue contrast. It is possible that these imaging technologies may lead to new diagnostic criteria or characterization above and beyond what has been described using 2-dimensional histology.
In Table 4, 3 clinical vignettes, which demonstrate the use and impact of clinical-grade IVM technologies, are presented.
Clinical Example 1: IVM-OCT of Esophagus: High-Grade Barrett Dysplasia With Invasive Adenocarcinoma
A 77-year-old man with a long history of gastroesophageal reflux, treated with pantoprazole, presented for endoscopic surveillance for Barrett esophagus. Although light endoscopy visualized circumferential changes consistent with Barrett esophagus, with a nonpolypoid lesion identified, endoscopic OCT with a balloon-centering catheter was performed during endoscopy with circumferential, volumetric scanning of the entire esophagus (Figure 1). In the upper esophagus, OCT visualized normal squamous mucosa of the esophagus with an orderly, densely layered arrangement of squamous epithelium, lamina propria, submucosa, inner muscularis propria, and outer muscularis propria. In the lower esophagus, OCT demonstrated numerous irregular glands with complex/cribriform contours and an intense signal at the mucosal surface, diagnostic of high-grade Barrett dysplasia. A non-polypoid lesion was identified that demonstrated destruction of the underlying architectural layers and a homogenized appearance of the esophageal wall, indicative of associated invasive adenocarcinoma. Biopsies were taken, which subsequently confirmed the OCT imaging interpretation.
This example demonstrates the use of IVM for targeted biopsy guidance. In this setting, the pathologist could provide a preliminary intraprocedural interpretation, similar in principle to rapid onsite evaluation or frozen section, to assist the gastroenterologist in biopsy site selection. This could be done either in the GI procedure suite or, potentially, via telepathology. Following the procedure, the imaging data could be sent to pathology along with the physical tissue biopsy for final pathologic interpretation.
Clinical Example 2: IVM-Reflectance Confocal Microscopy of Skin Lesion: Basal Cell Carcinoma
An 85-year-old woman presented to the dermatology clinic with a skin lesion on her posterior neck of unknown duration (Figure 2). Clinical skin exam revealed a 5-mm papule with irregular contour and pigmentation. Confocal microscopy images were obtained of the lesion in the clinic, which revealed disturbance of the normal honeycomb pattern of the epidermal surface in the region of the clinically observed papule. At an en face depth of 170 [micro]m, telangiectasia and a black tumor silhouette were observed. At a depth of 180 [micro]m, tumor islands were visualized with peripheral palisading and streaming. These confocal microscopy features were consistent with basal cell carcinoma. A biopsy was performed, which confirmed the confocal imaging interpretation of basal cell carcinoma.
This example demonstrates the use of IVM for primary diagnosis of skin lesions. Similar to clinical example 1, the pathologist could provide an intraprocedural interpretation, similar to frozen section, to assist the dermatologist in diagnosis of the lesion. Additionally, there is also the potential to use IVM for the identification of adequate margins during subsequent resection. This could be done either with an on-call pathologist in the clinic or via telepathology. Following the procedure, the imaging data could be sent to pathology along with the biopsy and/or tumor resection for final pathologic interpretation.
Clinical Example 3: IVM-OCT of Peripheral Lung: Usual Interstitial Pneumonitis
A 56-year-old man presented to a pulmonologist with a 4-month history of dyspnea. (20) Chest high-resolution computed tomography showed traction bronchiectasis and bibasilar, subpleural reticular opacities consistent with interstitial lung disease. However, the lack of honeycombing precluded a more specific diagnosis by high-resolution computed tomography. The patient underwent bronchoscopy and surgical lung biopsy for diagnosis, and endobronchial OCT was performed during bronchoscopy (Figure 3). OCT showed patchy loss of normal alveolated parenchyma in the peripheral lung. Destructive, signal-intense fibrosis was visualized with multifocal microscopic honeycombing, seen as irregular, cystic, signal-void spaces embedded within fibrosis. OCT visualized spatial heterogeneity as regions of preserved alveolar architecture intermixed with destructive fibrosis. The OCT imaging features were consistent with a diagnosis of usual interstitial pneumonitis. Subsequent surgical lung biopsy independently confirmed the diagnosis of usual interstitial pneumonitis, including the presence of peripheral destructive fibrosis, microscopic honeycombing, and spatial heterogeneity.
Many interstitial lung disease patients are unable to undergo surgical lung biopsy for diagnosis because of the risks of associated morbidity and mortality. This example demonstrates the use of IVM for primary diagnosis in an at-risk or compromised patient population where tissue biopsy may not be permissible or advisable. In this setting, IVM has the potential to replace traditional tissue biopsy. The IVM images may be interpreted by a pathologist intraprocedurally to ensure adequate diagnostic quality, much like the current frozen section of interstitial lung disease lung wedges is performed to ensure adequate diagnostic material is present. The IVM images could then be sent to pathology, in lieu of tissue, for final diagnostic interpretation.
In Table 5, 2 clinical vignettes, which demonstrate the use and impact of clinical-grade EVM technologies, are presented.
Clinical Example 4 (EVM, Confocal Microscopy): Adenocarcinoma of Lung
A 61-year-old woman with a 20-year smoking history presented to the emergency department with hemoptysis. She was found to have a mass involving the right upper and middle lobe by computed tomography scan without any evidence of involvement of mediastinal lymph nodes. She underwent surgical resection of the right upper and middle lobe of lung for removal of the mass. The surgical specimen showed a 5.0 X 4.8 X 3.4 cm tumor involving the right upper and middle lobe with direct invasion of the visceral pleura. A fragment of the lung tumor measuring 1.0 X 1.0 cm was imaged in the fresh state using a confocal fluorescence microscopy platform after staining the tissue with acridine orange for 6 seconds (Figure 4). Gray scale images, as well as images digitally psuedocolored to mimic histologic staining, were obtained for interpretation. Both types of images showed glandular features of invasive adenocarcinoma. The corresponding hematoxylin-eosinstained tissue section of the imaged tumor tissue confirmed features of moderately differentiated adenocarcinoma.
This EVM example is a prime illustration of using optical imaging to assist in selecting tissues for a variety of uses, including tissue block selection for frozen section, microscopic anatomic pathology assessment, and biobanking. The high resolution and pseudocolorization to more closely resemble traditional histologic staining provide a very close analog to traditional microscopy. The ability to visualize cellular detail in this manner would also have potential for rapid core biopsy adequacy assessment, without requiring consumption of tumor tissue.
Clinical Example 5 (EVM, OCT of Endomyometrium): Adenocarcinoma of Endometrium, Superficially Invasive
A 65-year-old woman presented with postmenopausal bleeding. The patient subsequently underwent total hysterectomy. Gross examination revealed a thickened, papillary endometrium without gross evidence of invasion into the myometrium. OCT imaging was performed ex vivo on the resection specimen to assess for depth of invasion (Figure 5). Based on imaging, the adenocarcinoma was superficially invasive into the myometrium, which was confirmed with traditional histologic sectioning.
This example illustrates the use of EVM to assist in gross assessment at the pathology bench, both for frozen section evaluation and for permanent section selection during grossing. This is applicable for tissue selection in other organ systems, such as prostate, gastroesophageal, breast, and lung resections for carcinoma.
WHY PATHOLOGISTS NEED TO EMBRACE THESE IMAGING TECHNOLOGIES
As demonstrated by the clinical vignettes, IVM and EVM have tremendous potential for clinical impact in a wide variety of applications. A summary of the Strengths, Weaknesses, Opportunities and Threats (SWOT analysis) for incorporating IVM and EVM into pathology practice is detailed in Table 6. Because of the similarities between IVM/EVM imaging features and traditional microscopy, and the overlapping skill sets required to interpret both, pathologists are ideally suited to assume the role of optical IVM/EVM expert. Compared with other clinical specialists who may consider introducing similar technologies into their practice, pathologists already have the skills and expertise to embrace such technologies. Pathologists are already experts at interpreting microscopic images. Pathologists are already trained to design and complete comprehensive validation procedures. Pathologists have been involved in numerous optical imaging validation studies, many of which included pathologist training on image interpretation and subsequent blinded validation assessment to determine interpretation sensitivity/specificity.* As clinical usage of these technologies develops further to assess a wider spectrum of disease, the pathologist's deep understanding of tissue microarchitecture and disease variability will be essential for accurate and clinically informative image interpretation and is a skill set no other clinical specialty currently has. Although not all of the imaging technologies provide direct 1:1 imaging to histology correlates, pathologists have the most comprehensive understanding of disease morphology from the gross to the ultramicroscopic level, which provides us with the best skill set to adapt our knowledge to optical image interpretation. Understanding biophysiologic correlates in tissue also allows pathologists to investigate additional diagnostic and prognostic markers that may be provided by other imaging modalities to complement those seen in thin, processed tissue sections under light microscopy. Embracing new optical imaging technologies could balance the reduction in surgical volumes associated with bundled payments, replace other labor-intensive procedures that have poor sensitivity and specificity (such as frozen sections), and reduce the number of repeat diagnostic biopsies due to inadequate tissue sampling. However, pathologists must be prepared to train themselves in the interpretation of new optical imaging modalities and consider the workflow and schedule changes that may accompany the introduction of these technologies into their daily practice. In vivo microscopy interpretation could be performed by pathologists intraprocedurally, similar to rapid assessment/frozen section, either with the pathologist in the procedure room or via telepathology. The IVM images could then be sent for final pathology interpretation, with or without accompanying tissue for traditional histology. Ex vivo microscopy could be performed and interpreted as part of the pathology workflow, either for rapid assessment of small tissue/biopsy or at the frozen section/grossing bench for large-area specimen imaging and targeted selection of tissue.
TRAINING OPPORTUNITIES FOR PATHOLOGISTS TO LEARN ABOUT IVM/EVM TECHNOLOGIES
In the same way that there is a learning curve for pathologists to interpret ultrasound images when performing fine-needle assessments on superficial lesions in the clinic setting or becoming comfortable with the software tools needed to diagnose and quantify digitized whole slide images, there is also a learning curve for interpreting IVM and EVM images. Numerous training and educational opportunities are available, including many resources provided by the College of American Pathologists and other professional associations, which are detailed in Table 7.
Pathologists today must actively embrace, learn about, and validate new technologies that can provide more cost-effective, standardized, and clinically relevant diagnoses for our patients. The College of American Pathologists, United States and Canadian Academy of Pathology, and Pathology Informatics associations have provided a wealth of resources and information to educate pathologists. Pathologists are already experts in interpreting microscopic images, particularly architectural and cytologic features as they relate to a specific diagnosis. They now need to master the interpretation of optical microscopy images. In addition to reflecting underlying patterns of disease understood from traditional microscopy, optical imaging comprises additional data that can potentially be leveraged to reveal previously unrealized features of disease and/or biochemical composition. Combining these features will allow pathologists to develop more comprehensive tissue and image-based signatures that may provide improved diagnostic accuracy and better predict patient prognosis and response to therapy.
(1.) Hariri LP, Mino-Kenudson M, Mark EJ, Suter MJ. In vivo optical coherence tomography: the role of the pathologist. Arch Pathol Lab Med. 2012;136(12): 1492-1501.
(2.) Huang D, Swanson EA, Lin CP, et al. Optical coherence tomography. Science. 1991;254(5035):1178-1181.
(3.) Tearney GJ, Brezinski ME, Bouma BE, et al. In vivo endoscopic optical biopsy with optical coherence tomography. Science. 1997;276(5321):2037-2039.
(4.) Brezinski ME, Tearney GJ, Bouma BE, et al. Optical coherence tomography for optical biopsy: properties and demonstration of vascular pathology. Circulation. 1996;93(6):1206-1213.
(5.) Drexler W, Morgner U, Kartner FX, et al. In vivo ultrahigh-resolution optical coherence tomography. Opt Lett. 1999;24(17):1221-1223.
(6.) Yun S, Tearney G, de Boer J, Iftimia N, Bouma B. High-speed optical frequency-domain imaging. Opt Express. 2003;11(22):2953-2963.
(7.) Yun S, Tearney G, Bouma B, Park B, de Boer J. High-speed spectral-domain optical coherence tomography at 1.3 mum wavelength. Opt Express. 2003; 11(26):3598-3604.
(8.) Yun S, Tearney G, de Boer J, Bouma B. Removing the depth-degeneracy in optical frequency domain imaging with frequency shifting. Opt Express. 2004; 12(20):4822-4828.
(9.) Yun SH, Tearney GJ, Vakoc BJ, et al. Comprehensive volumetric optical microscopy in vivo. Nat Med. 2006;12(12):1429-1433.
(10.) Braaf B, Vermeer KA, Sicam VA, van Zeeburg E, van Meurs JC, de Boer JF. Phase-stabilized optical frequency domain imaging at 1-pm for the measurement of blood flow in the human choroid. Opt Express. 2011;19(21):20886-20903.
(11.) Choma M, Sarunic M, Yang C, Izatt J. Sensitivity advantage of swept source and Fourier domain optical coherence tomography. Opt Express. 2003;11(18): 2183-2189.
(12.) Gora M, Karnowski K, Szkulmowski M, et al. Ultra high-speed swept source OCT imaging of the anterior segment of human eye at 200 kHz with adjustable imaging range. Opt Express. 2009;17(17):14880-14894.
(13.) Oh WY, Vakoc BJ, Shishkov M, Tearney GJ, Bouma BE. >400 kHz repetition rate wavelength-swept laser and application to high-speed optical frequency domain imaging. Opt Lett. 2010;35(17):2919-2921.
(14.) Adhi M, Duker JS. Optical coherence tomography-current and future applications. Curr Opin Ophthalmol. 2013;24(3):213-221.
(15.) Bussel II, Wollstein G, Schuman JS. OCT for glaucoma diagnosis, screening and detection of glaucoma progression. Br J Ophthalmol. 2014; 98(suppl 2):ii15-19.
(16.) Ko TH, Fujimoto JG, Schuman JS, et al. Comparison of ultrahigh- and standard-resolution optical coherence tomography for imaging macular pathology. Ophthalmology. 2005;112(11):1922.e1-15.
(17.) Spaide RF, Curcio CA. Anatomical correlates to the bands seen in the outer retina by optical coherence tomography: literature review and model. Retina. 2011;31(8):1609-1619.
(18.) Hariri LP, Mino-Kenudson M, Lanuti M, Miller AJ, Mark EJ, Suter MJ. Diagnosing lung carcinomas with optical coherence tomography. Ann Am Thorac Soc. 2015;12(2):193-201.
(19.) Adams DC, Hariri LP, Miller AJ, et al. Birefringence microscopy platform for assessing airway smooth muscle structure and function in vivo. Sci Transl Med. 2016;8(359):359ra131.
(20.) Hariri LP, Adams DC, Wain JC, et al. Endobronchial optical coherence tomography for low-risk microscopic assessment and diagnosis of idiopathic pulmonary fibrosis in vivo. Am J Respir Crit Care Med. 2018;197(7):949-952.
(21.) Patel NA, Stamper DL, Brezinski ME. Review of the ability of optical coherence tomography to characterize plaque, including a comparison with intravascular ultrasound. Cardiovasc Intervent Radiol. 2005;28(1):1-9.
(22.) Tearney GJ, Jang IK, Bouma BE. Optical coherence tomography for imaging the vulnerable plaque. J Biomed Opt. 2006;11(2):021002.
(23.) Chen Y, Aguirre AD, Hsiung PL, et al. Ultrahigh resolution optical coherence tomography of Barrett's esophagus: preliminary descriptive clinical study correlating images with histology. Endoscopy. 2007;39(7):599-605.
(24.) Evans JA, Poneros JM, Bouma BE, et al. Optical coherence tomography to identify intramucosal carcinoma and high-grade dysplasia in Barrett's esophagus. Clin Gastroenterol Hepatol. 2006;4(1):38-43.
(25.) Evans JA, Bouma BE, Bressner J, et al. Identifying intestinal metaplasia at the squamocolumnar junction by using optical coherence tomography. Gastrointest Endosc. 2007;65(1):50-56.
(26.) Bus MT, de Bruin DM, Faber DJ, et al. Optical diagnostics for upper urinary tract urothelial cancer: technology, thresholds, and clinical applications. J Endourol. 2015;29(2):113-123.
(27.) Gupta M, Su LM. Current and evolving uses of optical coherence tomography in the genitourinary tract. Curr Urol Rep. 2015;16(3):15.
(28.) Seitz U, Freund J, Jaeckle S, et al. First in vivo optical coherence tomography in the human bile duct. Endoscopy. 2001;33(12):1018-1021.
(29.) Hariri LP, Applegate MB, Mino-Kenudson M, et al. Optical frequency domain imaging of ex vivo pulmonary resection specimens: obtaining one to one image to histopathology correlation. J Vis Exp. 2013(71):e3855.
(30.) Isenberg G, Sivak MV, Chak A, et al. Accuracy of endoscopic optical coherence tomography in the detection of dysplasia in Barrett's esophagus: a prospective, double-blinded study. Gastrointest Endosc. 2005;62(6):825-831.
(31.) Poneros JM, Brand S, Bouma BE, Tearney GJ, Compton CC, Nishioka NS. Diagnosis of specialized intestinal metaplasia by optical coherence tomography. Gastroenterology. 2001;120(1):7-12.
(32.) Jackle S, Gladkova N, Feldchtein F, et al. In vivo endoscopic optical coherence tomography of esophagitis, Barrett's esophagus, and adenocarcinoma of the esophagus. Endoscopy. 2000;32(10):750-755.
(33.) Jackle S, Gladkova N, Feldchtein F, et al. In vivo endoscopic optical coherence tomography of the human gastrointestinal tract-toward optical biopsy. Endoscopy. 2000;32(10):743-749.
(34.) Sivak MV, Kobayashi K, Izatt JA, et al. High-resolution endoscopic imaging of the GI tract using optical coherence tomography. Gastrointest Endosc. 2000; 51(4, pt 1):474-479.
(35.) Suter MJ, Jillella PA, Vakoc BJ, et al. Image-guided biopsy in the esophagus through comprehensive optical frequency domain imaging and laser marking: a study in living swine. Gastrointest Endosc. 2010;71(2):346-353.
(36.) Vakoc BJ, Shishko M, Yun SH, et al. Comprehensive esophageal microscopy by using optical frequency-domain imaging (with video). Gastrointest Endosc. 2007;65(6):898-905.
(37.) Suter MJ, Gora MJ, Lauwers GY, et al. Esophageal-guided biopsy with volumetric laser endomicroscopy and laser cautery marking: a pilot clinical study. Gastrointest Endosc. 2014;79(6):886-896.
(38.) Tearney GJ, Waxman S, Shishkov M, et al. Three-dimensional coronary artery microscopy by intracoronary optical frequency domain imaging. JACC Cardiovasc Imaging. 2008;1(6):752-761.
(39.) Lam S, Standish B, Baldwin C, et al. In vivo optical coherence tomography imaging of preinvasive bronchial lesions. Clin Cancer Res. 2008;14(7):2006-2011.
(40.) Zagaynova E, Gladkova N, Shakhova N, Gelikonov G, Gelikonov V. Endoscopic OCT with forward-looking probe: clinical studies in urology and gastroenterology. J Biophotonics. 2008;1(2):114-128.
(41.) Mahmud MS, May GR, Kamal MM, et al. Imaging pancreatobiliary ductal system with optical coherence tomography: a review. World J Gastrointest Endosc. 2013,'5(11):540-550.
(42.) Ren H, Waltzer WC, Bhalla R et al. Diagnosis of bladder cancer with microelectromechanical systems-based cystoscopic optical coherence tomography. Urology. 2009;74(6):1351-1357.
(43.) Wessels R, De Bruin DM, Faber DJ, Van Leeuwen TG, Van Beurden M, Ruers TJ. Optical biopsy of epithelial cancers by optical coherence tomography (OCT). Lasers Med Sci. 2014;29(3):1297-1305.
(44.) Michel RG, Kinasewitz GT, Fung KM, Keddissi JI. Optical coherence tomography as an adjunct to flexible bronchoscopy in the diagnosis of lung cancer: a pilot study. Chest. 2010;138(4):984-948.
(45.) Tsuboi M, Hayashi A, Ikeda N, et al. Optical coherence tomography in the diagnosis of bronchial lesions. Lung Cancer. 2005;49(3):387-394.
(46.) Waxman S, Freilich MI, Suter MJ, et al. A case of lipid core plaque progression and rupture at the edge of a coronary stent: elucidating the mechanisms of drug-eluting stent failure. Circ Cardiovasc Interv. 2010;3(2):193-196.
(47.) Tearney GJ, Yabushita H, Houser SL, et al. Quantification of macrophage content in atherosclerotic plaques by optical coherence tomography. Circulation. 2003;107(1):113-119.
(48.) Burns JA, Kim KH, deBoer JF, Anderson RR, Zeitels SM. Polarization-sensitive optical coherence tomography imaging of benign and malignant laryngeal lesions: an in vivo study. Otolaryngol Head Neck Surg. 2011;145(1):91-99.
(49.) Burns JA. Optical coherence tomography: imaging the larynx. Curr Opin Otolaryngol Head Neck Surg. 2012;20(6):477-481.
(50.) Kim KH, Burns JA, Bernstein JJ, Maguluri GN, Park BH, de Boer JF. In vivo 3D human vocal fold imaging with polarization sensitive optical coherence tomography and a MEMS scanning catheter. Opt Express. 2010;180 4):14644--14653.
(51.) Guo S, Hutchison R, Jackson RP, et al. Office-based optical coherence tomographic imaging of human vocal cords. J Biomed Opt. 2006;11(3):30501.
(52.) Vokes DE, Jackson R, Guo S, et al. Optical coherence tomography-enhanced microlaryngoscopy: preliminary report of a noncontact optical coherence tomography system integrated with a surgical microscope. Ann Otol Rhinol Laryngol. 2008;117(7):538-547.
(53.) Wong BJ, Jackson RP, Guo S, et al. In vivo optical coherence tomography of the human larynx: normative and benign pathology in 82 patients. Laryngoscope. 2005;115(11):1904--1911.
(54.) Kawasaki M, Bouma BE, Bressner J, et al. Diagnostic accuracy of optical coherence tomography and integrated backscatter intravascular ultrasound images for tissue characterization of human coronary plaques. J Am Coll Cardiol. 2006;48(1):81-88.
(55.) Shostak E, Hariri LP, Cheng GZ, Adams DC, Suter MJ. Needle-based optical coherence tomography to guide transbronchial lymph node biopsy. J Bronchology Interv Pulmonol. 2018;25(3):189-197.
(56.) Hariri LP, Villiger M, Applegate MB, et al. Seeing beyond the bronchoscope to increase the diagnostic yield of bronchoscopic biopsy. Am J Respir Crit Care Med. 2013;187(2):125-129.
(57.) Hariri LP, Mino-Kenudson M, Applegate MB, et al. Toward the guidance of transbronchial biopsy: identifying pulmonary nodules with optical coherence tomography. Chest. 2013;144(4):1261-1268.
(58.) Hariri LP, Applegate MB, Mino-Kenudson M, et al. Volumetric optical frequency domain imaging of pulmonary pathology with precise correlation to histopathology. Chest. 2013;143(1):64-74.
(59.) Nguyen FT, Zysk AM, Chaney EJ, et al. Intraoperative evaluation of breast tumor margins with optical coherence tomography. Cancer Res. 2009;69(22): 8790-8796.
(60.) Suter MJ, Riker DR, Bouma BE, Beamis JF, Tearney GJ. Comprehensive microscopy of the swine and human pulmonary airways in vivo. Am J Respir Crit Care Med. 2009;179(179):A3536.
(61.) Hsiung PL, Phatak DR, Chen Y, Aguirre AD, Fujimoto JG, Connolly JL. Benign and malignant lesions in the human breast depicted with ultrahigh resolution and three-dimensional optical coherence tomography. Radiology. 2007;244(3):865-874.
(62.) Iftimia NV, MujatM, Ustun T, Ferguson RD, Danthu V, Hammer DX. Spectral-domain low coherence interferometry/optical coherence tomography system for fine needle breast biopsy guidance. Rev Sci Instrum. 2009;80(2):024302.
(63.) Lorenser D, Yang X, Kirk RW, Quirk BC, McLaughlin RA, Sampson DD. Ultrathin side-viewing needle probe for optical coherence tomography. Opt Lett. 2011;36(19):3894-3896.
(64.) Yang VX, Mao YX, Munce N, et al. Interstitial Doppler optical coherence tomography. Opt Lett. 2005;30(14):1791-1793.
(65.) Han S, Sarunic MV, Wu J, Humayun M, Yang C. Handheld forward-imaging needle endoscope for ophthalmic optical coherence tomography inspection. J Biomed Opt. 2008;13(2):020505.
(66.) Liang CP, Wierwille J, Moreira T, et al. A forward-imaging needle-type OCT probe for image guided stereotactic procedures. Opt Express. 2011;19(27): 26283-26294.
(67.) Li X, Chudoba C, Ko T, Pitris C, Fujimoto JG. Imaging needle for optical coherence tomography. Opt Lett. 2000;25(20):1520-1522.
(68.) Tan KM, Shishkov M, Chee A, Applegate MB, Bouma BE, Suter MJ. Flexible transbronchial optical frequency domain imaging smart needle for biopsy guidance. Biomed Opt Express. 2012;3(8):1947-1954.
(69.) Scolaro L, Lorenser D, McLaughlin RA, Quirk BC, Kirk RW, Sampson DD. High-sensitivity anastigmatic imaging needle for optical coherence tomography. Opt Lett. 2012;37(24):5247-5249.
(70.) Kuo WC, Kim J, Shemonski ND, Chaney EJ, Spillman DR, Boppart SA. Real-time three-dimensional optical coherence tomography image-guided coreneedle biopsy system. Biomed Opt Express. 2012;3(6):1149-1161.
(71.) Zhou C, Cohen DW, Wang Y, et al. Integrated optical coherence tomography and microscopy for ex vivo multiscale evaluation of human breast tissues. Cancer Res. 2010;70(24):10071-10079.
(72.) Zysk AM, Nguyen FT, Chaney EJ, et al. Clinical feasibility of microscopically-guided breast needle biopsy using a fiber-optic probe with computer-aided detection. Technol Cancer Res Treat. 2009;8(5):315-321.
(73.) Latrive A, Boccara AC. Invivo and insitu cellular imaging full-field-optical coherence tomography with a rigid endoscopic probe. Biomed Opt Express. 2011;2(10):2897-2904.
(74.) Curatolo A, McLaughlin RA, Quirk BC, et al. Ultrasound-guided optical coherence tomography needle probe for the assessment of breast cancer tumor margins. Am J Roentgenol. 2012;199(4):W520-W522.
(75.) Hariri LP, Bonnema GT, Schmidt K, et al. Laparoscopic optical coherence tomography imaging of human ovarian cancer. Gynecol Oncol. 2009;114(2): 188-194.
(76.) Gora MJ, Sauk JS, Carruth RW, et al. Tethered capsule endomicroscopy enables less invasive imaging of gastrointestinal tract microstructure. Nat Med. 2013;19(2):238-240.
(77.) Tabatabaei N, Kang D, Kim M, et al. Clinical translation of tethered confocal microscopycapsule for unse dated diagnosis of eosinophilic esophagitis. Sci Rep. 2018;8(1):2631.
(78.) Liang K, Traverso G, Lee HC, et al. Ultrahigh speed en face OCT capsule for endoscopic imaging. Biomed Opt Express. 2015;6(4): 1146-1163.
(79.) Liang K, Ahsen OO, Lee HC, et al. Volumetric mapping of Barrett's esophagus and dysplasia with en face optical coherence tomography tethered capsule. Am J Gastroenterol. 2016;111(11):1664-1666.
(80.) McLaughlin R, Quirk B, Curatolo A, et al. Imaging of breast cancer with optical coherence tomography needle probes: feasibility and initial results. IEEE J Sel Top Quantum Electron. 2012;18(3):1184-1191.
(81.) Liu L, Gardecki JA, Nadkarni SK, et al. Imaging the subcellular structure of human coronary atherosclerosis using micro-optical coherence tomography. Nat Med. 2011;17(8):1010-1014.
(82.) Zhou C, Wang Y, Aguirre AD, et al. Ex vivo imaging of human thyroid pathology using integrated optical coherence tomography and optical coherence microscopy. J Biomed Opt. 2010;15(1):016001.
(83.) Cui D, Chu KK, Yin B, et al. Flexible, high-resolution micro-optical coherence tomography endobronchial probe toward in vivo imaging of cilia. Opt Lett. 2017;42(4):867-870.
(84.) Chen Y, Andrews PM, Aguirre AD, Schmitt JM, Fujimoto JG. High-resolution three-dimensional optical coherence tomography imaging of kidney microanatomy ex vivo. J Biomed Opt. 2007;12(3):034008.
(85.) Committee AT. Confocal laser endomicroscopy. Gastrointest Endosc. 2014;80(6):928-938.
(86.) Wallace MB, Fockens P. Probe-based confocal laser endomicroscopy. Gastroenterology. 2009;136(5):1509-1513.
(87.) Eberl T, Jechart G, Probst A, et al. Can an endocytoscope system (ECS) predict histology in neoplastic lesions? Endoscopy. 2007;39(6):497-501.
(88.) Becker V, Wallace MB, Fockens P, et al. Needle-based confocal endomicroscopy for in vivo histology of intra-abdominal organs: first results in a porcine model (with videos). Gastrointest Endosc. 2010;71(7):1260-1266.
(89.) Becker V, von Delius S, Bajbouj M, Karagianni A, Schmid RM, Meining A. Intravenous application of fluorescein for confocal laser scanning microscopy: evaluation of contrast dynamics and image quality with increasing injection-to-imaging time. Gastrointest Endosc. 2008;68(2):319-323.
(90.) Bennassar A, Carrera C, Puig S, Vilalta A, Malvehy J. Fast evaluation of 69 basal cell carcinomas with ex vivo fluorescence confocal microscopy: criteria description, histopathological correlation, and interobserver agreement. JAMA Dermatol. 2013;149(7):839-847.
(91.) Shahriari N, Grant-Kels JM, Rabinovitz H, Oliviero M, Scope A. In vivo reflectance confocal microscopy image interpretation for the dermatopathologist. J Cutan Pathol. 2018;45(3):187-197.
(92.) Haroon A, Shafi S, Rao BK. Using reflectance confocal microscopy in skin cancer diagnosis. Dermatol Clin. 2017;35(4):457-464.
(93.) Rao BK, Mateus R, Wassef C, Pellacani G. In vivo confocal microscopy in clinical practice: comparison of bedside diagnostic accuracy of a trained physician and distant diagnosis of an expert reader. J Am Acad Dermatol. 2013; 69(6):e295-e300.
(94.) Thiberville L, Salaun M, Lachkar S, et al. Human in vivo fluorescence microimaging of the alveolar ducts and sacs during bronchoscopy. Eur Respir J. 2009;33(5):974-985.
(95.) Sonn GA, Jones SN, Tarin TV, et al. Optical biopsy of human bladder neoplasia with in vivo confocal laser endomicroscopy. J Urol. 2009;182(4):1299-1305.
(96.) Kiesslich R, Goetz M, Neurath MF. Confocal laser endomicroscopy for gastrointestinal diseases. Gastrointest Endosc Clin N Am. 2008;18(3):451-466, viii.
(97.) Meining A, Saur D, Bajbouj M, et al. In vivo histopathology for detection of gastrointestinal neoplasia with a portable, confocal miniprobe: an examiner blinded analysis. Clin Gastroenterol Hepatol. 2007;5(11):1261-1267.
(98.) Meining A, Schwendy S, Becker V, Schmid RM, Prinz C. In vivo histopathology of lymphocytic colitis. Gastrointest Endosc. 2007;66(2):398-399, discussion 400.
(99.) Hurlstone DP, Tiffin N, Brown SR, Baraza W, Thomson M, Cross SS. In vivo confocal laser scanning chromo-endomicroscopy of colorectal neoplasia: changing the technological paradigm. Histopathology. 2008;52(4):417-426.
(100.) Danilevskaya O, Averyanov A, Klimko N, et al. The case of diagnostics of invasive pulmonary aspergillosis by in vivo probe-based confocal laser endomicroscopy of central and distal airways. Med Mycol Case Rep. 2014;5:35-39.
(101.) Sorokina A, Danilevskaya O, Averyanov A, et al. Comparative study of ex vivo probe-based confocal laser endomicroscopy and light microscopy in lung cancer diagnostics. Respirology. 2014;19(6):907-913.
(102.) Jain M, Robinson BD, Shevchuk MM, et al. Multiphoton microscopy: a potential intraoperative tool for the detection of carcinoma in situ in human bladder. Arch Pathol Lab Med. 2015;139(6):796-804.
(103.) Fuchs FS, Zirlik S, Hildner K, Schubert J, Vieth M, Neurath MF. Confocal laser endomicroscopy for diagnosing lung cancer in vivo. Eur Respir J. 2013; 41(6):1401-1408.
(104.) Newton RC, Kemp SV, Shah PL, et al. Progress toward optical biopsy: bringing the microscope to the patient. Lung. 2011;189(2):111-119.
(105.) Newton RC, Kemp SV, Yang GZ, Elson DS, Darzi A, Shah PL. Imaging parenchymal lung diseases with confocal endomicroscopy. Respir Med. 2012; 106(1):127-137.
(106.) Salaun M, Bourg-Heckly G, Thiberville L. Confocal endomicroscopy of the lung: from the bronchus to the alveolus [in French]. Rev Mal Respir. 2010; 27(6):579-588.
(107.) Jabbour JM, Saldua MA, Bixler JN, Maitland KC. Confocal endomicroscopy: instrumentation and medical applications. Ann Biomed Eng. 2012;40(2): 378-397.
(108.) Spessotto P, Fornasarig M, Pivetta E, et al. Probe-based confocal laser endomicroscopy for in vivo evaluation of the tumor vasculature in gastric and rectal carcinomas. Sci Rep. 2017;7(1):9819.
(109.) Dunbar KB, Okolo P, Montgomery E, Canto MI. Confocal laser endomicroscopy in Barrett's esophagus and endoscopically inapparent Barrett's neoplasia: a prospective, randomized, double-blind, controlled, crossover trial. Gastrointest Endosc. 2009;70(4):645-654.
(110.) Neumann H, Langner C, Neurath MF, Vieth M. Confocal laser endomicroscopy for diagnosis of Barrett's esophagus. Front Oncol. 2012;2:42.
(111.) Wiesner C, Jager W, Salzer A, et al. Confocal laser endomicroscopy for the diagnosis of urothelial bladder neoplasia: a technology of the future? BJU Int. 2011;107(3):399-403.
(112.) Chen SP, Liao JC. Confocal laser endomicroscopy of bladder and upper tract urothelial carcinoma: a new era of optical diagnosis? Curr Urol Rep. 2014; 15(9):437.
(113.) Kahaleh M, Giovannini M, Jamidar P, et al. Probe-based confocal laser endomicroscopy for indeterminate biliary strictures: refinement of the image interpretation classification. Gastroenterol Res Pract. 2015;2015:675210.
(114.) Shieh FK, Drumm H, Nathanson MH, Jamidar PA. High-definition confocal endomicroscopy of the common bile duct. J Clin Gastroenterol. 2012; 46(5):401-406.
(115.) Wallace M, Lauwers GY, Chen Y, et al. Miami classification for probe-based confocal laser endomicroscopy. Endoscopy. 2011;43(10):882-891.
(116.) Napoleon B, Lemaistre AI, Pujol B, et al. In vivo characterization of pancreatic cystic lesions by needle-based confocal laser endomicroscopy (nCLE): proposition of a comprehensive nCLE classification confirmed by an external retrospective evaluation. Surg Endosc. 2016;30(6):2603-2612.
(117.) Charalampaki P, Javed M, Daali S, Heiroth HJ, Igressa A, Weber F. Confocal laser endomicroscopy for real-time histomorphological diagnosis: our clinical experience with 150 brain and spinal tumor cases. Neurosurgery. 2015; 62(suppl 1):171--176.
(118.) Krishna SG, Modi RM, Kamboj AK, et al. In vivo and ex vivo confocal endomicroscopy of pancreatic cystic lesions: a prospective study. World J Gastroenterol. 2017;23(18):3338-3348.
(119.) Krishna SG, Brugge WR, Dewitt JM, et al. Needle-based confocal laser endomicroscopy for the diagnosis of pancreatic cystic lesions: an international external interobserver and intraobserver study (with videos). Gastrointest Endosc. 2017;86(4):644-654.e2.
(120.) Nakai Y, Iwashita T, Park DH, Samarasena JB, Lee JG, Chang KJ. Diagnosis of pancreatic cysts: EUS-guided, through-the-needle confocal laser-induced endomicroscopy and cystoscopy trial: DETECT study. Gastrointest Endosc. 2015; 81(5):1204-1214.
Wendy A. Wells, MD, MSc; Michael Thrall, MD; Anastasia Sorokina, MD; Jeffrey Fine, MD; Savitri Krishnamurthy, MD; Attiya Haroon, MD; Babar Rao, MD; Maria M. Shevchuk, MD; Herbert C. Wolfsen, MD; Guillermo J. Tearney, MD, PhD; Lida P Hariri, MD, PhD
Accepted for publication October 4, 2018.
Published online December 10, 2018.
From the Department of Pathology, Dartmouth Hitchcock Medical Center, Lebanon, New Hampshire (Dr Wells); the Department of Pathology and Genomic Medicine, Houston Methodist Hospital, Houston, Texas (Dr Thrall); the Department of Pathology, University of Illinois at Chicago, Chicago (Dr Sorokina); the Department of Pathology, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania (Dr Fine); the Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston (Dr Krishnamurthy); the Department of Dermatology, Rutgers-Robert Wood Johnson Medical School, Somerset, New Jersey (Drs Haroon and Rao); the Department of Pathology, Weill Cornell Medical College, New York, New York (Dr Shevchuk); the Division of Gastroenterology & Hepatology, Mayo Clinic, Jacksonville, Florida (Dr Wolfsen); and the Wellman Center for Photomedicine (Dr Tearney) and the Department of Pathology (Drs Tearney and Hariri), Massachusetts General Hospital, Harvard Medical School, Boston.
Massachusetts General Hospital has a licensing arrangement with Terumo Corporation. Dr Tearney has the rights to receive royalties from this arrangement. Dr Tearney also receives royalties from iLumen, Nidek, and Abbott (through MIT). Dr Tearney has a financial/fiduciary interest in SpectraWave, a company developing an optical coherence tomography-near-infrared spectroscopy intracoronary imaging system and catheter. His financial/fiduciary interest was reviewed and is managed by the Massachusetts General Hospital and Partners HealthCare in accordance with their conflict of interest policies. Dr Tearney consults for NinePoint Medical and SpectraWave. Dr Tearney's laboratory receives materials from Terumo Corporation and sponsored research from Vivolight, iLumen, Boston Scientific, Ardea Biosciences, Vertex, and Canon Inc. Dr Rao is a consultant for CaliberlD, the maker of Vivascope. Dr Hariri is an author on a Massachusetts General Hospital-owned patent that has been licensed to LX Medical. Dr Hariri has the rights to receive royalties from the licensing arrangement. Dr Hariri is a consultant for LX Medical. The other authors have no relevant financial interest in the products or companies described in this article.
Corresponding author: Lida P. Hariri, MD, PhD, Department of Pathology, Massachusetts General Hospital, Harvard Medical School, 55 Fruit Street, Boston, MA 02114 (email: Lhariri@partners.org).
Caption: Figure 1. In vivo microscopy optical coherence tomography (OCT) of esophagus for Barrett surveillance. A and B, OCT image of normal squamous mucosa of the esophagus, obtained using a balloon-centering probe in vivo. A, OCT circumferential scan of the entire esophagus. B, Magnified region of A showing an orderly, densely layered arrangement of squamous epithelium (EP), lamina propria (LP), submucosa (SM), inner muscularis propria (IMP), and outer muscularis propria (OMP). C and D, OCT circumferential scan of the entire esophagus with lesion (arrows). D, Magnified region showing numerous irregular glands with complex/ cribriform contours and an intense signal at the mucosal surface, diagnostic of high-grade Barrett dysplasia (HGBD). The destruction of the underlying architectural layers and a homogenized appearance of the esophageal wall are indicative of associated invasive adenocarcinoma (IA). This example and figures were contributed by authors H. C. W. and G.J. T.
Caption: Figure 2. In vivo microscopy reflectance confocal microscopy (CM) for assessment of skin papule. A, A pigmented papule was observed on the skin surface of the posterior neck. B through D, Reflectance CM mosaic of skin surface, en face view. B, Disturbance of the normal honeycomb pattern of the epidermal surface in the area of the clinical papule. C, Reflectance CM en face depth of 170 pm with telangiectasia (yellow arrows) and a black tumor silhouette (red box). D, Reflectance CM en face depth of 180 pm with tumor islands with peripheral palisading and streaming (white star). The tumor islands seen are consistent with basal cell carcinoma. A biopsy was performed, which confirmed the diagnosis of basal cell carcinoma. This example and figures were contributed by authors A.H. and B.R.
Caption: Figure 3. In vivo microscopy optical coherence tomography (OCT) for assessment of interstitial lung disease. A, High-resolution computed tomography showed traction bronchiectasis (arrowhead) and bibasilar, subpleural reticular opacities (arrows), but no honeycombing. B, Endobronchial OCT showed microscopic features of usual interstitial pneumonitis (UIP), including multifocal microscopic honeycombing (arrowsHC) embedded within peripheral, destructive fibrosis (f) beyond the bronchiolar epithelium (e). C, Subsequent surgical lung biopsy was independently diagnosed as UIP, and it confirmed the presence of peripheral fibrosis (f), microscopic honeycombing (arrows), and preserved alveoli (a), indicative of spatial heterogeneity (a). D, Example of peripheral lung with numerous, evenly spaced alveoli present (a), indicative of spatial heterogeneity (hematoxylin-eosin, original magnification X40). This example and figures were contributed by author L.PH. Figure modified and reprinted with the permission of the American Thoracic Society Copyright 2018 American Thoracic Society. (20) The American Journal of Respiratory and Critical Care Medicine is an official journal of the American Thoracic Society.
Caption: Figure 4. Ex vivo confocal microscopy for assessment of lung carcinoma. A and B, Gray scale and digitally pseudocolored image of lung tumor tissue. The glandular differentiation of adenocarcinoma can be appreciated in the images. C, Corresponding hematoxylin-eosin-stained tissue section of the imaged tumor tissue confirms features of moderately differentiated adenocarcinoma (original magnification X200). This example and figures were contributed by author S.K.
Caption: Figure 5. Ex vivo microscopy optical coherence tomography (OCT) for the assessment of uterine endomyometrium. A, Ex vivo OCT image of fresh endomyometrium demonstrating endometrial adenocarcinoma with superficial invasion (white arrow). B, Corresponding routinely processed and hematoxylin-eosin-stained section of endomyometrium confirming the findings seen in OCT (black arrow) (original magnification X10). This example and the figures were contributed by author J.F.
* References 3, 4, 9, 24, 25, 29, 31, 34-36, 38, 42, 47, 54-59, 71, 72, 74-77, 80-83, 87, 91-93, 95, 97-103, 108-110, 116, 118, 119.
Table 1. Example Technologies Behind In Vivo Microscopy and Ex Vivo Microscopy 1. OCT Measures light reflectance, with contrast based on differences in endogenous tissue properties Provides cross-sectional images with near-cellular resolution of ~10 [micro]m Depth of penetration: 2-3 mm Image acquisition rates: up to 200 frames per second, allowing for rapid, 3-dimensional imaging of large tissue volumes OCT technology can be: Used for superficial applications, such as retinal imaging Catheter based for luminal organ imaging, with custom catheters for specific clinical applications Part of a swallowable capsule for upper GI tract screening Needle based or laparoscopic for solid organ imaging Commercially available Examples of use: GI tract (ie, Barrett esophagus, gastric lesions, colonic polyps, pancreatic cysts, inflammatory bowel disease) Coronary artery plaques Eye imaging (ie, retinal disease, choroidal disease) Pulmonary imaging (ie, lung nodules, interstitial lung disease, asthma) 2. CLE Detects fluorescence to generate image contrast from: Endogenous tissue autofluorescence, from structures such as collagen Exogenous fluorescent agents, such as fluorescein, injected intravenously or applied topically Provides images in the transverse, or "en face," plane with subcellular resolutions of 1-2 [micro]m Depth of penetration: up to 300 [micro]m FOV: up to 600 [micro]m Image acquisition rates: up to 12 frames per second Types of CLE probes: Probe-based devices with a fiber bundle that transmits the confocal image Endoscope-based devices with the confocal microscope scanner built into the endoscope Other endoscopic and needle-based confocal probes have also been developed Commercially available Examples of use: Skin lesions (ie, pigmented lesions, Mohs surgery for margins) GI tract (ie, Barrett esophagus, gastric lesions, colonic polyps, inflammatory bowel disease) Pulmonary imaging (ie, lung nodules, parenchymal lung disease) Cystoscopy (ie, bladder lesions, upper urinary tract lesions) Abbreviations: CLE, confocal laser endomicroscopy; FOV, field of view; GI, gastrointestinal; OCT, optical coherence tomography. Table 2. Current and Potential Applications of In Vivo Microscopy Organ Site Disease or Application Eye Retinal disease Choroidal disease Gastrointestinal Barrett esophagus and dysplasia tract Esophageal carcinoma, early stage Eosinophilic esophagitis Colorectal polyps Biliary strictures Pancreatic duct tumors Pancreatic cysts Inflammatory bowel disease Celiac disease Skin Melanocytic/nonmelanocytic tumors Melanocytic nevi Inflammatory skin lesions In vivo margin assessment Heart Plaque detection and morphology in coronary arteries Stent evaluation Lung Lung nodules/carcinoma Interstitial lung disease Asthma Chronic obstructive pulmonary disease Breast Biopsy guidance In vivo margin assessment Sentinel lymph node assessment Brain Brain tumors Genitourinary Bladder and upper tract urothelial lesions tract Gynecologic Cervical lesions Endometrial lesions Intraoperative Biopsy guidance in multiple organ systems or procedural Tumor margin assessment Table 3. Current and Potential Applications of Ex Vivo Microscopy Clinical Setting Pathology Application Example of Use Intraoperative or Tumor margin assessment Breast or lung Intraprocedural carcinoma resection margin assessment Needle biopsy/aspirate Rapid assessment of adequacy Transplant assessment Assessment of donor tissue suitability for transplant Gross examination Block selection--identify Esophageal, prostate, tumor-containing regions bladder, lung, breast resections for carcinoma Block selection--depth of Endometrial invasion carcinoma resection Melanoma resection Genomic-molecular Tissue triaging--selection Select tumor via studies imaging and conserve tissue Biobanking Tissue triaging--selection Select tumor-rich regions via imaging Clinical Setting Advantages Intraoperative or Alternative to Intraprocedural freezing the tissue No tissue consumption No need to freeze the tissue Gross examination More accurate selection of tissue sample In situ assessment of depth of invasion Genomic-molecular No need to freeze the tissue studies or wait for permanent sections Biobanking No need to freeze the tissue or wait for permanent sections Microscopic tissue documentation Conservation of tissue Table 4. Clinical Vignettes for In Vivo Microscopy (IVM) Example 1 2 Clinical Targeted biopsy Primary diagnosis, impact guidance and potential for margin assessment Organ system Esophagus Skin IVM modality IVM-OCT IVM-RCM Clinical 77-year-old man 85-year-old woman history with history of GE with 5-mm skin reflux treated with lesion, posterior pantoprazole neck, unknown duration Procedure Endoscopic surveillance Observed on for Barrett clinical exam esophagus Endoscopic/ Barrett, circumferential, Papule, irregular clinical/ with nonpolypoid contour and surgical lesion at 35 cm, pigmentation findings 5 o'clock IVM images Figure 1 Figure 2 Diagnosis High-grade dysplasia Basal cell and invasive carcinoma adenocarcinoma Example 3 Clinical Less invasive primary impact diagnosis in frail patient population Organ system Lung IVM modality IVM-OCT Clinical 56-year-old man history with interstitial lung disease, and nondiagnostic chest HRCT Procedure Bronchoscopy and VATS surgical lung biopsy for diagnosis Endoscopic/ Abnormal lung clinical/ parenchyma surgical findings IVM images Figure 3 Diagnosis Usual interstitial pneumonitis Abbreviations: GE, gastroesophageal; HRCT, high-resolution computed tomography; OCT, optical coherence tomography; RCM, reflectance confocal microscopy; VATS, video-assisted thoracoscopic surgery. Table 5. Clinical Vignettes for Ex Vivo Microscopy (EVM) Example 1 2 Clinical Tissue block Depth of invasion: application selection: endomyometrium lung cancer EVM modality EVM-CM EVM-OCT Clinical 61-year-old woman 65-year-old woman, history with lung mass postmenopausal bleeding Procedure Bilobectomy Total hysterectomy Gross 5.0-cm lung mass Thickened, papillary findings endometrium, grossly noninvasive of myometrium EVM images Figure 4 Figure 5 Diagnosis Adenocarcinoma Endometrial adenocarcinoma, of lung superficially invasive of myometrium Abbreviations: CM, confocal microscopy; OCT, optical coherence tomography. Table 6. Strengths, Weaknesses, Opportunities, Threats Analysis for In Vivo Microscopy (IVM) and Ex Vivo Microscopy (EVM) Strengths Weaknesses 1. Pathologists are already tissue 1. Pathologists are currently not imaging experts. trained in optical image interpretation. 2. Subspecialist pathologists are already working with subspecialist 2. It can be difficult for busy clinicians who can help validate pathologists/trainees to embrace new technology. and educate themselves about a new technology. 3. Pathologists must be involved 3. Workflow changes may require in the design of a validation coordinating schedules within the process (how and what tissues) and department, as well as the new workflows. operating room, endoscopy suites, and outpatient clinics. 4. Pathologists can incorporate new physiologic correlates 4. Pathologist reluctance to (vascularity patterns, water embrace digital images being sent content, tumor oxygenation) for to desktop workstations for rapid additional diagnostic or interpretation. prognostic "value." Opportunities Threats 1. Reduced surgical volumes--move 1. Resect and discard--faster from fee/for/service to bundled movement toward the "nonbiopsy payments, balanced with IVM/EVM diagnosis," supplanting the technology. diagnostic biopsy gold standard. 2. Advantages to patients--less 2. Other clinicians time in operating room, fewer (gastroenterologists, repeat biopsies, less inadequate dermatologists, surgeons) will tissue for diagnostic ancillary "claim" expertise. studies (molecular panels). 3. Replacement of other labor/ 3. Attitude impediments from intensive procedures with poor clinicians and pathologists. sensitivity/specificity (eg, frozen sections). 4. Encourage new instrument 4. Perceived increased costs of development by vendors (especially new technologies (capital outlay, in the field of EVM) and become no immediate reimbursement). involved in validation studies and early adoption. Table 7. Resources for Pathologists and Trainees to Learn About In Vivo Microscopy (IVM)/Ex Vivo Microscopy (EVM) National societies with IVM focus areas CAP IVM/EVM Work Group International Society for Optics and Photonics The Optical Society of America DPA CAP In Vivo Microscopy Resource Guide, including a complete bibliography and companion videos online CAP IVM webinar series (upcoming and archived) CAP IVM educational courses with practical demonstrations CAP Short Presentation in Emerging Concepts on IVM and EVM CAP IVM briefs on emerging technologies Pathology conferences with IVM topics CAP annual meeting Molecular Med TriCon DPA Pathology Informatics Summit Pathology Visions IVM fellowship programs Abbreviations: CAP, College of American Pathologists; DPA, Digital Pathology Association.
|Printer friendly Cite/link Email Feedback|
|Author:||Wells, Wendy A.; Thrall, Michael; Sorokina, Anastasia; Fine, Jeffrey; Krishnamurthy, Savitri; Haroon|
|Publication:||Archives of Pathology & Laboratory Medicine|
|Date:||Mar 1, 2019|
|Previous Article:||Next-Generation Microscopy: Optical Imaging for In Vivo and Ex Vivo Microscopy in Pathology.|
|Next Article:||Confocal Fluorescence Microscopy Platform Suitable for Rapid Evaluation of Small Fragments of Tissue in Surgical Pathology Practice.|